Sunday, August 29, 2021 8:54:32 AM
Wow!! LCY Biosciences aka the operators/manager of the Bioamber Sarnia plant are having tremendous success. Dex began the venture into this new product line in 2017 when they managed to produce 1MT and now as we approach 2022 we are closing in on 20,000 MT's; in one week LCY Biosciences has pumped out almost half of the total capacity of the Bioamber Sarnia plant; just over 14,000 MT's. At a discount rate of $1800 p/MT that's roughly $25m usd. I would say we are heading "for an eventual merger in the event of success".
Best Wishes,
IE
Best Wishes,
IE
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
